Health in Middle East, North Africa, Afghanistan & Pakistan 498 indicators covering health for Middle East, North Africa, Afghanistan & Pakistan. IndicatorLatest Year10-yr change Rank Maternal mortality ratio 47 2023 down 17.5% 36th Number of maternal deaths, per capita 0 units per person 2023 down 34.5% 34th Number of maternal deaths, per unit of GDP 0 units per US$ of GDP 2023 down 37.4% 31st Number of maternal deaths, per square kilometre 0.0004 units per square kilometre 2023 down 21.6% 32nd Number of maternal deaths, annual growth rate -4.08 % change on previous year 2023 down 149.0% 19th Probability of dying among adolescents ages 10-19 years 6.7 per 1,000 2024 down 16.2% 18th Probability of dying among children ages 5-9 years, female 2.4 per 1,000 2024 down 25.0% 18th Probability of dying among children ages 5-9 years, male 3 per 1,000 2024 down 23.1% 18th Probability of dying among adolescents ages 10-14 years, female 2.1 per 1,000 2024 down 19.2% 19th Probability of dying among adolescents ages 10-14 years, male 3 per 1,000 2024 down 14.3% 16th Probability of dying among adolescents ages 10-19 years, female 5 per 1,000 2024 down 15.3% 22nd Probability of dying among adolescents ages 10-19 years, male 8.4 per 1,000 2024 down 16.0% 18th Probability of dying among adolescents ages 15-19 years, female 2.9 per 1,000 2024 down 12.1% 22nd Probability of dying among adolescents ages 15-19 years, male 5.4 per 1,000 2024 down 16.9% 20th Probability of dying among youth ages 20-24 years, female 3.2 per 1,000 2024 down 3.0% 26th Probability of dying among youth ages 20-24 years, male 7.8 per 1,000 2024 down 14.3% 23rd Women's share of population ages 15+ living with HIV 29.3% 2024 down 3.1% 18th Prevalence of HIV, female 0.1% 2024 down 0.2% 21st Prevalence of HIV, male 0.1% 2024 down 0.2% 19th Prevalence of overweight, female 64.8% 2022 up 14.1% 8th Prevalence of overweight, male 57.0% 2022 up 18.5% 14th Prevalence of overweight 60.8% 2022 up 16.2% 10th Immunization, HepB3 84.4% 2024 up 5.8% 24th Newborns protected against tetanus 84.3% 2024 up 5.0% 12th Population ages 00-04, female 10.7% 2025 down 15.8% 17th Population ages 00-04, male 10.6% 2025 down 15.1% 17th Population ages 05-09, female 10.7% 2025 down 6.6% 17th Population ages 05-09, male 10.5% 2025 down 6.3% 17th Population ages 15-19, female 9.4% 2025 down 0.0% 16th Population ages 15-19, male 9.4% 2025 down 0.2% 17th Population ages 10-14, female 10.5% 2025 up 3.5% 17th Population ages 10-14, male 10.4% 2025 up 3.8% 16th Population ages 20-24, female 8.4% 2025 down 7.6% 21st Population ages 20-24, male 8.5% 2025 down 8.5% 20th Population ages 25-29, female 7.8% 2025 down 10.8% 18th Population ages 25-29, male 8.1% 2025 down 11.5% 8th Population ages 30-34, female 7.4% 2025 down 4.9% 12th Population ages 30-34, male 7.9% 2025 down 4.1% 7th Population ages 35-39, female 7.1% 2025 up 9.2% 22nd Population ages 35-39, male 7.5% 2025 up 10.4% 16th Population ages 40-44, female 6.3% 2025 up 16.1% 31st Population ages 40-44, male 6.6% 2025 up 16.1% 31st Population ages 45-49, female 5.2% 2025 up 12.0% 32nd Population ages 45-49, male 5.3% 2025 up 12.6% 32nd Population ages 50-54, female 4.3% 2025 up 9.6% 34th Population ages 50-54, male 4.3% 2025 up 11.6% 33rd Population ages 55-59, female 3.6% 2025 up 14.0% 34th Population ages 55-59, male 3.5% 2025 up 14.7% 32nd Population ages 60-64, female 2.9% 2025 up 19.9% 34th Population ages 60-64, male 2.7% 2025 up 19.8% 34th Population ages 65-69, female 2.3% 2025 up 25.6% 34th Population ages 65-69, male 2.0% 2025 up 25.3% 34th Population ages 70-74, female 1.6% 2025 up 28.7% 34th Population ages 70-74, male 1.3% 2025 up 27.0% 33rd Population ages 75-79, female 1.0% 2025 up 19.7% 32nd Population ages 75-79, male 0.8% 2025 up 18.1% 33rd Population ages 80 and above, female 0.8% 2025 up 15.7% 31st Population ages 80 and above, male 0.6% 2025 up 10.7% 32nd Population ages 00-04, female 43.23 million 2025 up 1.1% 22nd Population ages 00-04, male 45.26 million 2025 up 0.6% 22nd ← Previous Page 5 of 9 Next →